KetoSwiss is a Swiss-based biotech startup that develops ketone body supplements to provide an alternative energy source for individuals with metabolic disorders. Their product, MigraKet, specifically targets migraine management by utilizing the neuroprotective properties of ketones to alleviate symptoms.
Funding
$10.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
TWFounders
Product
Problem
Individuals with metabolic disorders often lack efficient energy production pathways, leading to fatigue and other complications. Migraine sufferers experience debilitating headaches and neurological symptoms that significantly impact their quality of life.
Solution
KetoSwiss develops ketone body supplements designed to provide an alternative energy source, particularly for individuals with metabolic disorders and migraine sufferers. Their flagship product, MigraKet, leverages the neuroprotective properties of ketones to potentially alleviate migraine symptoms. By providing an alternative fuel source for the brain, MigraKet aims to reduce the frequency and severity of migraine attacks. The supplement is now available for purchase in the US, with plans for international expansion.
Target Audience
The primary target audience includes individuals with metabolic disorders seeking alternative energy sources and migraine sufferers looking for ways to manage their symptoms.
Features
- Utilizes ketone bodies as an alternative energy source for the brain.
- Designed to potentially reduce migraine frequency and severity.
- Aims to provide neuroprotective benefits through ketone supplementation.
- Currently available for purchase in the US.